The research projects conducted by the Oral Cancer Research Center will utilize tissue samples from a common pool of patients. Tissues will be stored in a common tissue bank. This centralization facilitates the provision of common management information and statistical consulting services. Preliminary calculations showed that the projected tissue accrual will yield acceptable statistical power even if only a small fraction of the patients can provide useable data on any given project. Specifically, 300 useable patients out of a total projected accrual of 1,500 would yield a power of at least 80% to detect clinical effects observed in other studies of integrins and proteinases. A computerized data base will be designed, implemented and maintained. The data base will allow tracking of patient demographic and clinical information and information derived from tissue samples. Biostatistical consulting will be provided on an individualized basis to the research projects. The primary endpoint will be disease-free survival, but marker status will also be correlated with clinical stage and other variables of interest. In addition, the results of the individual research projects will be integrated using multivariate statistical techniques. This will allow for the estimation of the simultaneous effect of different markers and may serve to derive risk scores for future clinical use.

Agency
National Institute of Health (NIH)
Institute
National Institute of Dental & Craniofacial Research (NIDCR)
Type
Specialized Center (P50)
Project #
5P50DE011912-04
Application #
6218983
Study Section
Project Start
1999-09-21
Project End
2000-07-31
Budget Start
1998-10-01
Budget End
1999-09-30
Support Year
4
Fiscal Year
1999
Total Cost
Indirect Cost
Name
University of California San Francisco
Department
Type
DUNS #
073133571
City
San Francisco
State
CA
Country
United States
Zip Code
94143
Bortoluzzi, Marcelo C; Yurgel, Liliane S; Dekker, Nusi P et al. (2004) Assessment of p63 expression in oral squamous cell carcinomas and dysplasias. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 98:698-704
Sethi, Neerja; Palefsky, Joel (2003) Treatment of human papillomavirus (HPV) type 16-infected cells using herpes simplex virus type 1 thymidine kinase-mediated gene therapy transcriptionally regulated by the HPV E2 protein. Hum Gene Ther 14:45-57
Stern, Robert; Shuster, Svetlana; Neudecker, Birgit A et al. (2002) Lactate stimulates fibroblast expression of hyaluronan and CD44: the Warburg effect revisited. Exp Cell Res 276:24-31
Mio, Kazuhiro; Stern, Robert (2002) Inhibitors of the hyaluronidases. Matrix Biol 21:31-7
Regezi, Joseph A; Ramos, Daniel M; Pytela, Robert et al. (2002) Tenascin and beta 6 integrin are overexpressed in floor of mouth in situ carcinomas and invasive squamous cell carcinomas. Oral Oncol 38:332-6
Nicoll, Steven B; Barak, Ory; Csoka, Antonei B et al. (2002) Hyaluronidases and CD44 undergo differential modulation during chondrogenesis. Biochem Biophys Res Commun 292:819-25
Shuster, Svetlana; Frost, Gregory I; Csoka, Antonei B et al. (2002) Hyaluronidase reduces human breast cancer xenografts in SCID mice. Int J Cancer 102:192-7
Mio, K; Csoka, A B; Nawy, S S et al. (2001) Detecting hyaluronidase and hyaluronidase inhibitors. Hyaluronan-substrate gel and -inverse substrate gel techniques. Methods Mol Biol 171:391-7
Lin, G; Stern, R (2001) Plasma hyaluronidase (Hyal-1) promotes tumor cell cycling. Cancer Lett 163:95-101
Nawy, S S; Csoka, A B; Mio, K et al. (2001) Hyaluronidase activity and hyaluronidase inhibitors. Assay using a microtiter-based system. Methods Mol Biol 171:383-9

Showing the most recent 10 out of 32 publications